-
Mashup Score: 0Highlights From the 2024 World Conference on Lung Cancer - 6 hour(s) ago
At the 2024 World Conference on Lung Cancer, more than 7,000 clinicians and scientists gathered in San Diego in celebration of the 50th anniversary of the International Association for the Study of Lu…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Hitting the Right Notes: Meet the Adverse Events | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Mary Ellen Schneider is a medical journalist based in Setauket, New York. What do you get when you take a classical pianist, a classic rock guitar player, a music teacher, and a financial planner, and add some hematology and oncology physicians? The answer is the Adverse Events, an eight-member cover band that will be playing classic rock and pop favorites from the 1970s through the 2000s at this year’s ASH-a-Palooza trainee event on Friday afternoon, December 8, in San Diego as part of the 65th American
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Hitting the Right Notes: Meet the Adverse Events | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Mary Ellen Schneider is a medical journalist based in Setauket, New York. What do you get when you take a classical pianist, a classic rock guitar player, a music teacher, and a financial planner, and add some hematology and oncology physicians? The answer is the Adverse Events, an eight-member cover band that will be playing classic rock and pop favorites from the 1970s through the 2000s at this year’s ASH-a-Palooza trainee event on Friday afternoon, December 8, in San Diego as part of the 65th American
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Meet the Trainee Council - 1 year(s) ago
Fellows are invited to apply for a position on the Trainee Council. Trainees who exhibit leadership qualities and a high potential for a successful career in hematology or a hematology-related discipline are desired candidates.
Source: www.hematology.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Paper: Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Early Relapsed/Refractory Multiple Myeloma - 2 year(s) ago
Oral and Poster Abstracts 653. Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Poster I Research, clinical trials, Clinical Research, Combination therapy, Therapies Anupama Kumar, MD1, Aaron S Rosenberg, MD2, Michelle Padilla3*, Nina Shah, MD4, Lindsey Sirianni1*, Lin Liu, PhD5*, Yuwei Cheng1*, Emily Pittman, PhD3*, Dimitrios Tzachanis,…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
We love to see familiar faces in the @ASCOPost! Congratulations to this issue’s guest editors, Dr. @PatelOncology and 2nd year fellow Dr. @TaliAzen! Check out their highlights from the 2024 WCLC! https://t.co/wAY9A5ZX6W